Multicancer Blood Test, Combined with Imaging, Shows Promise as Screen for Cancer
The blood test followed by PET-CT imaging was 99.6% specific for cancer.
Read MorePosted by | May 4, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types |
The blood test followed by PET-CT imaging was 99.6% specific for cancer.
Read MorePosted by | May 4, 2020 | Molecular Diagnostics, Research |
Public Health England will use PerkinElmer’s EnLite Neonatal TREC kit at three of six sites to screen newborns for this rare inherited genetic condition.
Read MorePosted by | Apr 27, 2020 | Cancer, Molecular Diagnostics |
Ambry’s +RNAinsight adds RNA testing to DNA multigene panels, improving diagnostic yield.
Read MorePosted by | Apr 21, 2020 | Cancer, Molecular Diagnostics, Prostate |
Prostate cancer patients above the high-risk threshold with a Prolaris score greater than 2.112 saw a statistically significant benefit from multimodality therapy.
Read MorePosted by | Apr 16, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The new saliva collection method will allow for broader population screening for covid-19 than the current method of nose and throat swabs.
Read More